Medicine and Dentistry
Non-Hodgkin Lymphoma
100%
Oncology
77%
Doxorubicin
67%
Vincristine
60%
Cyclophosphamide
56%
Disease
53%
CHOP
46%
Neoplasm
46%
Diffuse Large B-Cell Lymphoma
43%
Prednisone
41%
Overall Survival
38%
Large-Cell Lymphoma
37%
Radiation Therapy
31%
Follicular Lymphoma
27%
Rituximab
26%
Gene Expression
25%
Combination Chemotherapy
25%
B Cell
24%
Progression Free Survival
24%
Hodgkin's Lymphoma
21%
Tositumomab
21%
Phase II Trials
21%
Prognostic Factor
19%
Breast Cancer
17%
Gene Expression Profiling
17%
Iodine 131
16%
T Cell
16%
Clinical Trial
16%
Nodular Melanoma
15%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
14%
Bleomycin
13%
Methotrexate
13%
Chemotherapy Regimens
12%
B-Cell Lymphoma
12%
Major Histocompatibility Complex
12%
Large Cell
11%
Molecular Profiling
11%
Malignant Neoplasm
10%
Alisertib
10%
Immune Checkpoint Inhibitor
10%
Esorubicin
10%
Skin Defect
10%
Mitoxantrone
10%
Patient with Non-Hodgkins Lymphoma
9%
Lymphoma
9%
Germinal Center
9%
Nuclease
9%
Etoposide
9%
Biopsy
9%
Involved-Field Radiotherapy
8%
Immunophenotyping
8%
Cell Lineage
8%
Peripheral T-Cell Lymphoma
7%
Mitomycin
7%
Cisplatin
7%
Histocompatibility Antigen
7%
Formaldehyde
7%
T Lymphocyte
7%
Group Trial
7%
Folinic Acid
7%
Immunocompetent Cell
7%
Positron Emission Tomography
7%
Computer Assisted Tomography
7%
Follicular Lymphoma International Prognostic Index
7%
Histiocytic Lymphoma
7%
Lymphoproliferative Disease
7%
Interferon
7%
Mantle Cell Lymphoma
6%
Immunosurveillance
6%
Adenocarcinoma
6%
Lung Cancer
6%
Multivariate Analysis
6%
Adverse Event
6%
Protein Expression
6%
Interferon Alfa 2b
6%
Salvage Therapy
6%
Medicare
6%
Lymphoblastic Lymphoma
6%
Prospective Study
5%
CD8 Antigen
5%
Self Concept
5%
Leukemia
5%
Recurrence Free Survival
5%
Colon
5%
Radioimmunotherapy
5%
Monoclonal Antibody
5%
Methylprednisolone
5%
Gemcitabine
5%
Molecular Diagnosis
5%
Burkitt's Lymphoma
5%
Dermatology
5%
Beta 1 Adrenergic Receptor
5%
Systematic Review
5%
Galiximab
5%
Drug Megadose
5%
Image Quality
5%
Mucosa-Associated Lymphoid Tissue
5%
Non-Hodgkin Lymphoma Cell Line
5%
Social Media
5%
Anaplastic Large Cell Lymphoma
5%
Keyphrases
Southwest Oncology Group
35%
Chemotherapy
23%
Group Studies
21%
Outcome-based Contracts
21%
Pricing Method
21%
Diffuse Large B-cell Lymphoma (DLBCL)
20%
Doxorubicin
20%
High-grade non-Hodgkin Lymphoma
18%
Non-Hodgkin Lymphoma
16%
Malignant Lymphoma
16%
Progression-free Survival
16%
Bis-pyrene
15%
Meta-analysis
15%
Lymphoma Patients
15%
Prednisone
15%
Cyclophosphamide
15%
Unfavorable Histology
13%
Non-small Cell Lung Cancer (NSCLC)
13%
Lymphoma
13%
Complete Remission
13%
Overall Survival
12%
Follicular Lymphoma
12%
Osimertinib
12%
Phase II Study
12%
Phase II Trial
12%
Methotrexate
11%
Confidence Interval
11%
Radiotherapy
11%
Melanoma
11%
Monte Carlo Simulation
10%
MACOP-B
10%
High Dose
10%
Erasmus Darwin
10%
Aesthetic Form
10%
Romantic Period
10%
Mitoxantrone
10%
T Cells
10%
Talimogene Laherparepvec (T-VEC)
10%
VP16
10%
L2 Learning
10%
Henry James
10%
Economic Evaluation
10%
Combination Therapy
10%
Ipilimumab
10%
Initial Treatment
9%
Acquisition Cost
9%
Involved Field Radiotherapy
8%
Partial Response
8%
Gameful
8%
Prospective Cohort Study
8%
Outcome-based Pricing
8%
Etoposide
8%
Bleomycin
8%
Cooperative Group
8%
Hodgkin Disease
7%
Quality-adjusted Life Years
7%
Doxorubicin-cyclophosphamide
7%
B Cell Phenotype
7%
Teaching English to Speakers of Other Languages (TESOL)
7%
Clinical Trials
7%
Burkitt
7%
International Prognostic Index
7%
L2 Writing
7%
Genre-based Writing
7%
Genre-based
7%
Genre Analysis
7%
Complete Response
6%
Gene Expression Profiling
6%
Group Setting
6%
Molecular Diagnostics
6%
Willingness to Pay
6%
Objective Response Rate
6%
Adriamycin
6%
Combination Chemotherapy
6%
Histiocytic Lymphoma
6%
Genre Awareness
6%
Writing Course
6%
Incremental Cost-effectiveness Ratio
6%
Chemosensitizer
6%
Chemotherapy Alone
6%
Resistant Disease
6%
Reference Dependence
6%
Monotherapy
6%
Tositumomab
6%
Clinically Localized
6%
Intermediate Grade
5%
Complete Response Rate
5%
Objective Response
5%
Bulky Disease
5%
No Significant Difference
5%
Median Survival
5%
P-glycoprotein Expression
5%
Platinum-etoposide
5%
Peripheral T Cells
5%
T-cell non-Hodgkin Lymphoma
5%
Gemcitabine
5%
Bridging Activities
5%
Sociopragmatics
5%
Pragmatic Awareness
5%
Heart Failure
5%
Arts and Humanities
Genre
22%
Classroom
15%
Scholars
12%
Corpus
12%
Learner corpus
12%
Teaching Process
10%
Erasmus Darwin
10%
Second language writing
10%
Henry James
10%
Media Education
7%
Second language
7%
Romantic era
7%
L2 writing
7%
Genre Analysis
7%
Palestinians
6%
Corpus data
5%
Modernism
5%
Communities of Practices (CoPs)
5%
Meaning making
5%
Popular Science
5%
ESL students
5%
open letter
5%
Wisdom
5%
Present tense
5%
Dada
5%
Film noir
5%
Online
5%
Appalachia
5%
Borderlands
5%
history books
5%
Modernist novels
5%
Language Proficiency
5%
Relational
5%
Regular
5%
Conferences
5%
second-language research
5%
Discourse genre
5%
Historical Inquiry
5%
Subaltern
5%
Poem
5%
Victor Turner
5%
Awareness
5%
Subjectivity
5%
King Arthur
5%
Articulation
5%
Moby-Dick
5%
Post-human
5%
Vows
5%
ESL writing
5%
post-war years
5%
Professional Development
5%
Elizabethan
5%
Linguistic Description
5%
Roman Jakobson
5%
Banjo
5%
Critical applied linguistics
5%
Student writing
5%
Public Engagement
5%
Linguistic Expression
5%
Feminist film theory
5%
Hitchcock
5%
Alfred Hitchcock
5%
Inclusivity
5%
Mutilation
5%
mermaid
5%
Remake
5%
Consumerism
5%
Cohort
5%
In-depth interviews
5%
Sailors
5%
Language minority students
5%
Narrative
5%
Crowds
5%
Detectives
5%
Critical edition
5%
Anglo-Norman
5%
Literary Imagination
5%
Identity markers
5%
Guy Fawkes
5%
Saturnalia
5%
Borrowing
5%
dislike
5%
Misrule
5%
Persona
5%
Excess
5%
Figurative
5%
vanity
5%
Gluttony
5%
Cambridge Companion
5%
Seattle
5%
Media Studies
5%
Civility
5%
Transnational
5%
Rhetorical Form
5%
Liberation
5%
Conception
5%
Mobile
5%
scholarly edition
5%
Science Fiction
5%
Local
5%